Search by Drug Name or NDC
NDC 43538-0170-69 Clindacin P 10 mg/mL Details
Clindacin P 10 mg/mL
Clindacin P is a TOPICAL SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Medimetriks Pharmaceuticals, Inc.. The primary component is CLINDAMYCIN PHOSPHATE.
MedlinePlus Drug Summary
Topical clindamycin is used to treat acne. Clindamycin is in a class of medications called lincomycin antibiotics. It works by slowing or stopping the growth of bacteria that cause acne and by decreasing swelling.
Related Packages: 43538-0170-69Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Clindamycin Topical
Product Information
| NDC | 43538-0170 |
|---|---|
| Product ID | 43538-170_46465f9a-1b07-4044-9598-55a211b95297 |
| Associated GPIs | 90051010109420 |
| GCN Sequence Number | 022140 |
| GCN Sequence Number Description | clindamycin phosphate MED. SWAB 1 % TOPICAL |
| HIC3 | Q5W |
| HIC3 Description | TOPICAL ANTIBIOTICS |
| GCN | 45411 |
| HICL Sequence Number | 004045 |
| HICL Sequence Number Description | CLINDAMYCIN PHOSPHATE |
| Brand/Generic | Brand |
| Proprietary Name | Clindacin P |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | clindamycin phosphate |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | SOLUTION |
| Route | TOPICAL |
| Active Ingredient Strength | 10 |
| Active Ingredient Units | mg/mL |
| Substance Name | CLINDAMYCIN PHOSPHATE |
| Labeler Name | Medimetriks Pharmaceuticals, Inc. |
| Pharmaceutical Class | Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA065049 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 43538-0170-69 (43538017069)
| NDC Package Code | 43538-170-69 |
|---|---|
| Billing NDC | 43538017069 |
| Package | 69 APPLICATOR in 1 JAR (43538-170-69) / 1 mL in 1 APPLICATOR |
| Marketing Start Date | 2022-11-14 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |